Meer Patel

Experience

• 

  Columbia University

  May 2017 - Aug 2019

  Research Assistant

  Studied the migration of cortical interneurons in the medial ganglionic eminence to develop a better transgenic mice models of neurodegenerative diseases.

• 

  The Johns Hopkins University School of Medicine

  Sept 2019 - May 2021

  Research Assistant

  Research assistant in the Institue of Cell Engineering to study the molecular mechanisms of α-synuclein in Parkinson's disease and tau in Alzheimer's disease under Dr. Xiaobo Mao.

• 

  FlexMed

  Jan 2020 - now

  Co-Founder & Project Leader

  Medical device startup working towards the creation of a wearable patch that monitors parameters commonly associated with inflammation in order to provide physicians and patients with a real-time quantification of the health of a postoperative surgical site.

• 

  Johns Hopkins Center for Bioengineering Innovation & Design

  Mar 2020 - now

  Developing a non-invasive method of measuring intracranial pressure in order to enact timely and proactive treatments for patients with intracranial disorders. In collaboration with the Laboratory of Computational Intensive Care Medicine (LCICM) at the Johns Hopkins Hospital. Prototyping and clinically testing a novel device for the management of vesicovaginal fistulae in low-resource settings to alleviate social distress caused by physical symptoms. In collaboration with Dr. Grace Chen at Johns Hopkins Hospital. Developing a less time-intensive method to decrease the viscosity of saliva samples in order to increase the rate of sample processing for detection of SARS-CoV-2. In collaboration with Danaher and Dr. William Clark at Johns Hopkins Hospital.

  • Design Team Member at ICPredict

    Mar 2021 - now

  • R&D Engineer at Obstreticare

    Dec 2019 - now

  • Clinical Lead at Saligenics Biomarker Saliva Processing

    Mar 2020 - now
• 

  The National Institutes of Health

  May 2021 - Aug 2021

  Research Assistant

  Examined the molecular and cellular mechanisms of dopamine and its activation of neurodegenerative processes in the mammalian brain under Dr. Jean Lud Cadet at the National Institute of Drug Abuse (NIDA).